Initial Statement of Beneficial Ownership (3)
August 23 2019 - 4:05PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
CHAKOUTIS PETER M |
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/8/2019
|
3. Issuer Name and Ticker or Trading Symbol
Biostage, Inc. [BSTG]
|
(Last)
(First)
(Middle)
C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, SUITE 11 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Vice President of Finance / |
(Street)
HOLLISTON, MA 07146
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | (1) | 5/29/2028 | Common Stock, par value $0.01 per share | 38052 | $2.72 | D | |
Stock Option (Right to Buy) | (2) | 8/8/2029 | Common Stock, par value $0.01 per share | 30000 | $2.29 | D | |
Explanation of Responses: |
(1) | This stock option vests in four equal installments, including installments that vested on May 29, 2018 and May 29, 2019, those that vest on May 29, 2020, and May 29, 2021. |
(2) | This stock option vests in twelve consecutive equal quarterly installments commencing on November 8, 2019. |
Remarks: Exhibit List: Exhibit 24 - Limited Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
CHAKOUTIS PETER M C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, SUITE 11 HOLLISTON, MA 07146 |
|
| Vice President of Finance |
|
Signatures
|
/s/ Chad J. Porter, by power of attorney | | 8/19/2019 |
**Signature of Reporting Person | Date |
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Apr 2023 to Apr 2024